Break Up Big Medicine Act
Sponsor
Full profile: /officials/W000817
Source: Congress.gov · FEC
Cosponsors (1)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Plain-English Summary
This bill would give the federal government new tools to break apart large healthcare companies and hospital systems that are deemed too dominant in their markets, similar to antitrust actions against other large corporations. The goal is to increase competition in healthcare and potentially lower costs for patients by preventing a small number of companies from controlling too much of the medical industry. It would affect major hospital chains, insurance companies, and other large healthcare providers.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- S4648A bill to improve transparency with respect to foreign influence on Department of Defense contractors.Referred to Committee · 2026-06-01
- S4550Maternal Health Pandemic Response ActReferred to Committee · 2026-05-18
- SRES732A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.Referred to Committee · 2026-05-14
- S4509PBM ActReferred to Committee · 2026-05-13